Device Trial Radar · NCT06572410
Prospective Analysis of EnVisio Spatial Intelligence for Soft Tissue Localization and Guided Surgical Excision
Last checked: Nov 20, 2026Latest source record: Aug 27, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
200
Planned (sponsor's estimate)
Start
Aug 7, 2024
Primary completion
Feb 1, 2026
Study completion Feb 15, 2026
Sponsor
- Lead sponsor
- Elucent MedicalNot on our public-company list
- Sponsor type
- Industry
- First posted
- Aug 27, 2024
Design
- Study type
- Observational
- FDA-regulated device
- Yes
- Who can join
- Female only, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Observational study. The purpose of this study is to evaluate the use of real-time surgical navigation for the localization and surgical removal of soft tissue tumors. The goal is to collect information about the efficiency and effectiveness of the EnVisio Surgical Navigation for intraoperative guidance to obtain negative margin on initial specimen. Prospective Patient Study: 200 consecutive patients
Conditions
- Tumors, Breast
Interventions
EnVisio Navigation SystemDevice
Patient will be undergoing BCS Breast Conserving Surgery treatment for DCIS or invasive breast cancer with EnVisio Navigation System.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Margin PositivityTime frame: Day of Surgery
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Advent Winter Garden
Winter Garden, Florida · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.